Search research articles
Contact Us
Filters
Showing results (51-60 of 167) with videos related to
Page
of 17
Sort By:
American Journal of Infection Control
|
January 25, 2011
Investigating the impact of the definition of previous antibiotic exposure related to isolation of extended spectrum β-lactamase-producing Klebsiella pneumoniae
Suprat Saely, Keith S Kaye, Marilynn R Fairfax, et al.
Infectious Disease Clinics of North America
|
May 22, 2016
Agents of Last Resort: Polymyxin Resistance
Keith S Kaye, Jason M Pogue, Thien B Tran, et al.
The Journal of Antimicrobial Chemotherapy
|
April 10, 2024
Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections
Walaiporn Wangchinda, Jason M Pogue, Visanu Thamlikitkul, et al.
Microbiology Spectrum
|
May 31, 2022
A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints
Vikas Gupta, Kalvin C Yu, Jason M Pogue, et al.
Infection and Drug Resistance
|
September 27, 2018
Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant <i>Enterobacteriaceae</i>
Lindsay A Petty, Oryan Henig, Twisha S Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 12, 2023
Executive Summary: State-of-the-Art Review: State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms
Arsheena Yassin, Mariya Huralska, Jason M Pogue, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2023
State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms
Arsheena Yassin, Mariya Huralska, Jason M Pogue, et al.
The Journal of Antimicrobial Chemotherapy
|
June 26, 2018
Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model
Katie E Barber, Jason M Pogue, Henderson D Warnock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 6, 2014
Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center
Jason M Pogue, Anupama Neelakanta, Ryan P Mynatt, et al.
Infectious Disease Clinics of North America
|
October 4, 2020
Agents of Last Resort: An Update on Polymyxin Resistance
Qiwen Yang, Jason M Pogue, Zekun Li, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 167) with videos related to
Sort By:
Page
of 17
American Journal of Infection Control
|
January 25, 2011
Investigating the impact of the definition of previous antibiotic exposure related to isolation of extended spectrum β-lactamase-producing Klebsiella pneumoniae
Suprat Saely, Keith S Kaye, Marilynn R Fairfax, et al.
Infectious Disease Clinics of North America
|
May 22, 2016
Agents of Last Resort: Polymyxin Resistance
Keith S Kaye, Jason M Pogue, Thien B Tran, et al.
The Journal of Antimicrobial Chemotherapy
|
April 10, 2024
Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections
Walaiporn Wangchinda, Jason M Pogue, Visanu Thamlikitkul, et al.
Microbiology Spectrum
|
May 31, 2022
A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints
Vikas Gupta, Kalvin C Yu, Jason M Pogue, et al.
Infection and Drug Resistance
|
September 27, 2018
Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant <i>Enterobacteriaceae</i>
Lindsay A Petty, Oryan Henig, Twisha S Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 12, 2023
Executive Summary: State-of-the-Art Review: State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms
Arsheena Yassin, Mariya Huralska, Jason M Pogue, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2023
State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms
Arsheena Yassin, Mariya Huralska, Jason M Pogue, et al.
The Journal of Antimicrobial Chemotherapy
|
June 26, 2018
Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model
Katie E Barber, Jason M Pogue, Henderson D Warnock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 6, 2014
Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center
Jason M Pogue, Anupama Neelakanta, Ryan P Mynatt, et al.
Infectious Disease Clinics of North America
|
October 4, 2020
Agents of Last Resort: An Update on Polymyxin Resistance
Qiwen Yang, Jason M Pogue, Zekun Li, et al.
Page
of 17